SI3121169T1 - Postopki sinteze in/ali čiščenja spojin diaminofenotiazina - Google Patents
Postopki sinteze in/ali čiščenja spojin diaminofenotiazinaInfo
- Publication number
- SI3121169T1 SI3121169T1 SI200732186T SI200732186T SI3121169T1 SI 3121169 T1 SI3121169 T1 SI 3121169T1 SI 200732186 T SI200732186 T SI 200732186T SI 200732186 T SI200732186 T SI 200732186T SI 3121169 T1 SI3121169 T1 SI 3121169T1
- Authority
- SI
- Slovenia
- Prior art keywords
- purification
- synthesis
- methods
- diaminophenothiazinium compounds
- diaminophenothiazinium
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
- C07D279/18—[b, e]-condensed with two six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
- C07D279/18—[b, e]-condensed with two six-membered rings
- C07D279/20—[b, e]-condensed with two six-membered rings with hydrogen atoms directly attached to the ring nitrogen atom
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US81962706P | 2006-07-11 | 2006-07-11 | |
EP16173815.8A EP3121169B1 (en) | 2006-07-11 | 2007-07-10 | Methods of synthesis and/or purification of diaminophenothiazinium compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
SI3121169T1 true SI3121169T1 (sl) | 2022-05-31 |
Family
ID=38669650
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200731596T SI2457904T1 (sl) | 2006-07-11 | 2007-07-10 | Postopki sinteze in/ali čiščenje diaminofenotiazinijevih spojin |
SI200731836A SI2457905T1 (sl) | 2006-07-11 | 2007-07-10 | Postopki sinteze in/ali čiščenja diaminofenotiazinijevih spojin |
SI200731284T SI2057136T1 (sl) | 2006-07-11 | 2007-07-10 | Postopki sinteze in/ali čiščenja diaminofenotiazinijevih spojin |
SI200732186T SI3121169T1 (sl) | 2006-07-11 | 2007-07-10 | Postopki sinteze in/ali čiščenja spojin diaminofenotiazina |
Family Applications Before (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200731596T SI2457904T1 (sl) | 2006-07-11 | 2007-07-10 | Postopki sinteze in/ali čiščenje diaminofenotiazinijevih spojin |
SI200731836A SI2457905T1 (sl) | 2006-07-11 | 2007-07-10 | Postopki sinteze in/ali čiščenja diaminofenotiazinijevih spojin |
SI200731284T SI2057136T1 (sl) | 2006-07-11 | 2007-07-10 | Postopki sinteze in/ali čiščenja diaminofenotiazinijevih spojin |
Country Status (17)
Country | Link |
---|---|
US (9) | US7956183B2 (sl) |
EP (5) | EP3121169B1 (sl) |
JP (2) | JP5350237B2 (sl) |
CN (2) | CN102718730B (sl) |
AU (1) | AU2007274057B2 (sl) |
CA (1) | CA2657352C (sl) |
CY (1) | CY1118184T1 (sl) |
DK (4) | DK2057136T3 (sl) |
ES (4) | ES2421930T3 (sl) |
HK (1) | HK1129675A1 (sl) |
HU (1) | HUE030621T2 (sl) |
LT (1) | LT2457905T (sl) |
MY (2) | MY162313A (sl) |
PL (4) | PL2457904T3 (sl) |
PT (4) | PT3121169T (sl) |
SI (4) | SI2457904T1 (sl) |
WO (1) | WO2008007074A2 (sl) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1799662B1 (en) | 2004-09-23 | 2013-04-17 | Wista Laboratories Ltd. | Methods of chemical synthesis and purification of diaminophenothiazinium compounds including methylthioninium chloride (mtc) |
ATE478058T3 (de) | 2006-03-29 | 2010-09-15 | Wista Lab Ltd | 3,7-diamino-10h-phenothiazinsalze und ihre verwendung |
WO2008007074A2 (en) | 2006-07-11 | 2008-01-17 | Wista Laboratories Ltd. | Methods of synthesis and/or purification of diaminophenothiazinium compounds |
FR2903696B1 (fr) * | 2006-07-12 | 2011-02-11 | Provence Technologies | Procede de purification de composes diaminophenothiazium |
US9211294B2 (en) | 2007-06-19 | 2015-12-15 | Wista Laboratories Ltd. | Phenothiazine compounds for treating mild cognitive impairment |
EP2205245B1 (en) * | 2007-10-03 | 2015-06-24 | WisTa Laboratories Ltd. | Therapeutic use of diaminophenothiazines |
MX2011005979A (es) * | 2008-12-09 | 2011-06-27 | Interquim Sa | Procedimiento de obtencion de (6s)-(-)-5,6,7,8-tetrahidro-6-[propi l-(2-tienil)etil]amino-1-naftol(rotigotina). |
US8785434B2 (en) | 2010-04-30 | 2014-07-22 | Prosetta Antiviral Inc. | Antiviral compounds |
DE102010062810B4 (de) * | 2010-09-07 | 2014-03-13 | Immungenetics Ag | 2-(R2-Thio)-10-[3-(4-R1-piperazin-1-yl)propyl]-10H-phenothiazine zur Behandlung neurodegenerativer Erkrankungen ausgewählt aus beta-Amyloidopathien und alpha-Synucleinopathien |
ES2594703T3 (es) | 2011-02-11 | 2016-12-22 | Wista Laboratories Ltd. | Sales de fenotiazin diamonio y sus usos |
WO2012145567A1 (en) | 2011-04-20 | 2012-10-26 | Prosetta Antiviral Inc. | Antiviral compounds |
RU2535073C1 (ru) * | 2013-07-18 | 2014-12-10 | Федеральное государственное бюджетное учреждение науки "Научно-исследовательский институт общей реаниматологии имени В.А. Неговского" Российской академии медицинских наук | Способ лечения метгемоглобинемии |
NZ630569A (en) * | 2013-08-15 | 2017-06-30 | Eupharma Pty Ltd | Process for the purification of diaminophenothiazinium compounds |
GB201317702D0 (en) * | 2013-10-07 | 2013-11-20 | Wista Lab Ltd | Methods of chemical synthesis of diaminophenothiazinium compounds including methylthioninium chloride (MTC) |
FR3015481B1 (fr) * | 2013-12-20 | 2016-08-12 | Etat Francais Represente Par Le Delegue General Pour L'armement | Utilisation de composes de diaminophenothiazinium en tant qu'agents de prevention, reduction ou suppression d'une radiotoxicite |
CN103864717B (zh) * | 2014-04-04 | 2015-11-11 | 山东理工大学 | 一种针状亚甲基白晶体的制备方法 |
US10364227B2 (en) | 2015-02-17 | 2019-07-30 | Arizona Board Of Regents On Behalf Of Arizona State University | Therapeutic compounds |
AU2016220096B2 (en) | 2015-02-17 | 2020-01-30 | Arizona Board Of Regents On Behalf Of Arizona State University | Phenothiazine analogues as mitochondrial therapeutic agents |
GB201512678D0 (en) * | 2015-07-20 | 2015-08-26 | Wista Lab Ltd | Methods of chemical synthesis |
CN105399703B (zh) * | 2015-12-15 | 2018-02-13 | 江苏恒润制药有限公司 | 一种亚甲基蓝的制备方法 |
CN105541756B (zh) * | 2015-12-17 | 2018-02-09 | 陕西方舟制药有限公司 | 一种制备1‑(3,7‑双二甲氨基‑吩噻嗪‑10‑基)乙酮的方法 |
ITUA20163526A1 (it) | 2016-05-17 | 2017-11-17 | Icrom Spa | Procedimento per la preparazione di composti diamminofenotiazinici ad elevato grado di purezza |
DK3487505T3 (da) | 2016-07-25 | 2023-05-30 | Wista Lab Ltd | Indgivelse og dosering af diaminophenothiaziner |
US11390605B2 (en) | 2016-08-25 | 2022-07-19 | Arizona Board Of Regents On Behalf Of Arizona State University | Substituted pyrimidine compounds as multifunctional radical quenchers and their uses |
US10745366B2 (en) | 2016-08-25 | 2020-08-18 | Arizon Board Of Regents On Behalf Of Arizona State University | Therapeutic compounds |
GB201614834D0 (en) | 2016-09-01 | 2016-10-19 | Wista Lab Ltd | Treatment of dementia |
GB201621817D0 (en) | 2016-12-21 | 2017-02-01 | Wista Lab Ltd | Methods of chemical synthesis |
WO2018126107A1 (en) | 2016-12-29 | 2018-07-05 | Board Of Regents, The University Of Texas System | Methylene blue solution for the treatment of oral lesions |
CN110505906A (zh) * | 2017-01-10 | 2019-11-26 | 得克萨斯州A&M大学系统 | 甲磺酸介导的共轭多孔聚合物网络的无溶剂合成 |
FR3063495B1 (fr) * | 2017-03-02 | 2019-04-05 | Provepharm Life Solutions | Procede de preparation de l’iodure de 3,7-bis(dimethylamino)phenothiazine-5-ylium |
EP3375777A1 (en) | 2017-03-15 | 2018-09-19 | MIKROCHEM spol. s.r.o. | Method for preparation of 3,7-bis-(dimethylamino)-phenothiazin-5-ium chloride or bromide |
US11350853B2 (en) | 2018-10-02 | 2022-06-07 | Under Armour, Inc. | Gait coaching in fitness tracking systems |
CN109337681B (zh) * | 2018-11-22 | 2020-05-08 | 南京工业大学 | 一种硫氮共掺杂的碳量子点的制备方法和应用 |
TR201818670A2 (tr) | 2018-12-05 | 2020-06-22 | Eti Gida Sanayi Ve Ticaret Anonim Sirketi | Sızıntı yapmayan gıda dolgu maddesi depozitör sistemi. |
US20220049102A1 (en) * | 2019-09-21 | 2022-02-17 | RK Pharma Solutions LLC | Process for the Purification of Methylene Blue |
CN114656424B (zh) * | 2022-03-16 | 2023-06-27 | 深圳先进技术研究院 | 一种上转换长余辉化学发光成像纳米探针及其制备方法和应用 |
CN114806211B (zh) * | 2022-03-16 | 2023-04-07 | 深圳先进技术研究院 | 一种疏水性亚甲蓝荧光染料及其制备方法和应用 |
WO2023202464A1 (zh) * | 2022-04-19 | 2023-10-26 | 英科隆生物技术(杭州)有限公司 | 一种电子媒介体的提纯方法 |
CN114507193B (zh) * | 2022-04-19 | 2022-06-24 | 英科隆生物技术(杭州)有限公司 | 电子媒介体天青c的提纯方法 |
WO2023232764A1 (en) | 2022-05-31 | 2023-12-07 | Wista Laboratories Ltd. | Treatment of neurodegenerative disorders utilising methylthioninium (mt)-containing compounds |
CN114989113A (zh) * | 2022-06-01 | 2022-09-02 | 山东科源制药股份有限公司 | 一种药用亚甲基蓝的精制方法 |
WO2024063700A1 (en) | 2022-09-21 | 2024-03-28 | Yin Sze Loh | Oral formulation of diaminophenothiazines and methods of making and using the same in the treatment and/or prevention of diseases |
EP4342451A1 (en) | 2022-09-22 | 2024-03-27 | Galenicum Health SLU | Pharmaceutical compositions and manufacturing methods thereof |
US20240115579A1 (en) | 2022-09-22 | 2024-04-11 | Galenicum Health S.L.U. | Pharmaceutical compositions and manufacturing methods thereof |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1886C (de) | 1877-12-15 | 1877-12-15 | Basf Ag | Verfahren zur darstellung blauer farbstoffe aus dimethylanilin und anderen tertiaeren aromatischen monaminen |
DE103147C (de) * | 1898-06-07 | 1899-04-05 | Cohn Georg | Verfahren zur darstellung von acetylleukomethylenblau und -äthylenblau. |
DE113721C (de) * | 1899-06-01 | 1900-09-28 | Verfahren zur Darstellung von Acidylderivaten der Leukothioninfarbstoffe | |
US3395018A (en) * | 1964-04-29 | 1968-07-30 | Du Pont | Light-sensitive color-forming composition |
US3641016A (en) * | 1968-02-16 | 1972-02-08 | Egyt Gyogyszervegyeszeti Gyar | Thionine derivatives |
DE2515966C3 (de) | 1975-04-11 | 1979-11-22 | Boehringer Mannheim Gmbh, 6800 Mannheim | Vorgefärbte Objektträger für die Blutunte rsuchung |
US4003892A (en) | 1975-04-17 | 1977-01-18 | Serva-Entwicklungslabor V. Grothe & Co. | Method of separating thionine and its N-methyl derivatives from each other |
US4212971A (en) | 1979-03-08 | 1980-07-15 | American Cyanamid Company | Process for preparing methylene blue |
JPS6385644A (ja) * | 1986-09-30 | 1988-04-16 | Ricoh Co Ltd | 電子写真現像剤用トナ− |
US5344928A (en) | 1991-04-26 | 1994-09-06 | Takeda Chemical Industries, Ltd. | Phenothiazine derivatives, their production and use |
US6238931B1 (en) * | 1993-09-24 | 2001-05-29 | Biosite Diagnostics, Inc. | Fluorescence energy transfer in particles |
GB9506197D0 (en) | 1995-03-27 | 1995-05-17 | Hoffmann La Roche | Inhibition of tau-tau association. |
AU740547B2 (en) | 1997-01-21 | 2001-11-08 | American National Red Cross, The | Intracellular and extracellular decontamination of whole blood and blood components by amphiphilic phenothiazin-5-ium dyes plus light |
JP2000344685A (ja) | 1999-03-26 | 2000-12-12 | Bf Kenkyusho:Kk | アズールa類似化合物によるアミロイドが蓄積する疾患の画像診断プローブおよびそれを含む画像診断用組成物 |
IT1307270B1 (it) | 1999-10-12 | 2001-10-30 | Dideco Spa | Procedimento e dispositivo per la determinazione della concentrazionedi eparina in un campione di fluido. |
JP2003531828A (ja) | 2000-02-26 | 2003-10-28 | アドバンスト フォトダイナミック テクノロジーズ, インコーポレイテッド | 光感光性物質および界面活性剤を使用する、光力学的な細胞および無細胞生物の根絶 |
FR2810318B1 (fr) | 2000-06-15 | 2005-09-23 | Laurent Galey | Derives de diamano-phenothiazine |
GB0101049D0 (en) | 2001-01-15 | 2001-02-28 | Univ Aberdeen | Materials and methods relating to protein aggregation in neurodegenerative disease |
GB2373787A (en) | 2001-03-08 | 2002-10-02 | Univ Central Lancashire | Phenothiazinium derivatives and their use to reduce pathogenic contaminants |
GB0106953D0 (en) | 2001-03-20 | 2001-05-09 | Univ Aberdeen | Neufofibrillary labels |
GB0113121D0 (en) | 2001-05-30 | 2001-07-18 | Univ Leeds | Biologically active photosensitisers |
US7176308B2 (en) * | 2002-06-17 | 2007-02-13 | Verification Technologies, Inc. | Processes for preparing novel methylene blue derivative |
GB0322756D0 (en) | 2003-09-29 | 2003-10-29 | Univ Aberdeen | Methods of chemical synthesis |
AU2004295148A1 (en) * | 2003-11-28 | 2005-06-16 | Photopharmica Limited | Developments in biologically active methylene blue derivatives (2) |
EP1799662B1 (en) | 2004-09-23 | 2013-04-17 | Wista Laboratories Ltd. | Methods of chemical synthesis and purification of diaminophenothiazinium compounds including methylthioninium chloride (mtc) |
CN101084204B (zh) | 2004-09-23 | 2012-12-05 | 卫思道制药有限公司 | 包括亚甲蓝(mtc)在内的二氨基吩噻嗪鎓化合物的化学合成和纯化方法 |
ATE478058T3 (de) | 2006-03-29 | 2010-09-15 | Wista Lab Ltd | 3,7-diamino-10h-phenothiazinsalze und ihre verwendung |
WO2008007074A2 (en) | 2006-07-11 | 2008-01-17 | Wista Laboratories Ltd. | Methods of synthesis and/or purification of diaminophenothiazinium compounds |
FR2903696B1 (fr) * | 2006-07-12 | 2011-02-11 | Provence Technologies | Procede de purification de composes diaminophenothiazium |
ES2594703T3 (es) | 2011-02-11 | 2016-12-22 | Wista Laboratories Ltd. | Sales de fenotiazin diamonio y sus usos |
DK3487505T3 (da) | 2016-07-25 | 2023-05-30 | Wista Lab Ltd | Indgivelse og dosering af diaminophenothiaziner |
GB201614834D0 (en) | 2016-09-01 | 2016-10-19 | Wista Lab Ltd | Treatment of dementia |
GB201621817D0 (en) | 2016-12-21 | 2017-02-01 | Wista Lab Ltd | Methods of chemical synthesis |
EP4364801A2 (en) | 2018-07-26 | 2024-05-08 | WisTa Laboratories Ltd. | Optimised dosage of diaminophenothiazines in populations |
GB201909454D0 (en) | 2019-07-01 | 2019-08-14 | Wista Lab Ltd | Enhancers |
GB201909506D0 (en) | 2019-07-02 | 2019-08-14 | Wista Lab Ltd | Synaptopathies |
-
2007
- 2007-07-10 WO PCT/GB2007/002570 patent/WO2008007074A2/en active Application Filing
- 2007-07-10 CN CN201210195299.1A patent/CN102718730B/zh active Active
- 2007-07-10 SI SI200731596T patent/SI2457904T1/sl unknown
- 2007-07-10 AU AU2007274057A patent/AU2007274057B2/en active Active
- 2007-07-10 EP EP16173815.8A patent/EP3121169B1/en active Active
- 2007-07-10 MY MYPI2012001462A patent/MY162313A/en unknown
- 2007-07-10 EP EP11173334.1A patent/EP2457904B1/en active Active
- 2007-07-10 SI SI200731836A patent/SI2457905T1/sl unknown
- 2007-07-10 ES ES07733509T patent/ES2421930T3/es active Active
- 2007-07-10 CA CA2657352A patent/CA2657352C/en active Active
- 2007-07-10 DK DK07733509.9T patent/DK2057136T3/da active
- 2007-07-10 EP EP07733509.9A patent/EP2057136B1/en active Active
- 2007-07-10 PL PL11173334T patent/PL2457904T3/pl unknown
- 2007-07-10 ES ES11173334.1T patent/ES2529714T3/es active Active
- 2007-07-10 PT PT161738158T patent/PT3121169T/pt unknown
- 2007-07-10 SI SI200731284T patent/SI2057136T1/sl unknown
- 2007-07-10 ES ES11173338.2T patent/ES2603783T3/es active Active
- 2007-07-10 PL PL07733509T patent/PL2057136T3/pl unknown
- 2007-07-10 DK DK11173338.2T patent/DK2457905T3/en active
- 2007-07-10 CN CN2007800336078A patent/CN101511803B/zh active Active
- 2007-07-10 SI SI200732186T patent/SI3121169T1/sl unknown
- 2007-07-10 PL PL11173338T patent/PL2457905T3/pl unknown
- 2007-07-10 PT PT77335099T patent/PT2057136E/pt unknown
- 2007-07-10 PL PL16173815T patent/PL3121169T3/pl unknown
- 2007-07-10 EP EP11173338.2A patent/EP2457905B1/en active Active
- 2007-07-10 PT PT111733341T patent/PT2457904E/pt unknown
- 2007-07-10 MY MYPI20090099A patent/MY148145A/en unknown
- 2007-07-10 PT PT111733382T patent/PT2457905T/pt unknown
- 2007-07-10 EP EP22153513.1A patent/EP4063354A1/en active Pending
- 2007-07-10 JP JP2009518955A patent/JP5350237B2/ja active Active
- 2007-07-10 DK DK16173815.8T patent/DK3121169T3/da active
- 2007-07-10 HU HUE11173338A patent/HUE030621T2/en unknown
- 2007-07-10 LT LTEP11173338.2T patent/LT2457905T/lt unknown
- 2007-07-10 DK DK11173334.1T patent/DK2457904T3/en active
- 2007-07-10 ES ES16173815T patent/ES2912571T3/es active Active
- 2007-07-10 US US12/373,216 patent/US7956183B2/en active Active
-
2009
- 2009-09-25 HK HK09108805.9A patent/HK1129675A1/xx unknown
-
2011
- 2011-05-31 US US13/149,164 patent/US8440821B2/en active Active
-
2013
- 2013-05-09 US US13/890,607 patent/US9382220B2/en active Active
- 2013-08-21 JP JP2013171087A patent/JP6243659B2/ja active Active
-
2016
- 2016-06-17 US US15/185,803 patent/US9675621B2/en active Active
- 2016-11-03 CY CY20161101128T patent/CY1118184T1/el unknown
-
2017
- 2017-06-09 US US15/619,199 patent/US9980971B2/en active Active
-
2018
- 2018-05-23 US US15/987,354 patent/US10525061B2/en active Active
-
2019
- 2019-11-15 US US16/685,420 patent/US11045477B2/en active Active
-
2021
- 2021-06-23 US US17/355,336 patent/US11878021B2/en active Active
-
2023
- 2023-12-08 US US18/533,515 patent/US20240115580A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL3121169T3 (pl) | Sposoby syntezy i/lub oczyszczania związków diaminofenotiazyniowych | |
IL196956A0 (en) | Aza-benzofuranyl compounds and methods of use | |
EP2023718A4 (en) | CREATINLIGATE COMPOUNDS AND APPLICATION METHOD THEREFOR | |
IL187361A0 (en) | Methods of purifying tigecycline | |
IL185077A0 (en) | Purification of rapamycin | |
IL197060A0 (en) | Aza-benzothiophenyl compounds and methods of use | |
IL194028A0 (en) | Tetrahydropyridothienopyrimidine compounds and methods of use thereof | |
HK1134295A1 (en) | Compounds and methods for synthesis and purification of oligonucleotides | |
HK1135099A1 (en) | Aza-indolyl compounds and methods of use | |
GB0608190D0 (en) | Method of purification | |
IL185309A0 (en) | Isoqunoline compounds and methods of use thereof | |
TWI368621B (en) | Stereoselective synthesis of β-nucleosides | |
ZA200802893B (en) | Purification of water | |
HK1084290A1 (en) | Synthesis and application of chlorin e6 zn-complex | |
ZA200900896B (en) | Aza-benzofuranyl compounds and methods of use | |
GB0618703D0 (en) | Synthesis of leikotriene compounds | |
PL2198431T3 (pl) | Oczyszczanie metali | |
IL184570A0 (en) | Purification of oligonucleotides | |
GB0914782D0 (en) | Perfluoroparacyclophane and methods of synthesis and use thereof | |
GB2437540B (en) | Fastening of pipes | |
ZA200901009B (en) | Aza-benzothiophenyl compounds and methods of use | |
SI2038260T1 (sl) | Stereoselektivna sinteza (S)-1-metil-3-fenilpiperazina | |
GB0602832D0 (en) | Synthesis of cyanohydrins | |
PT1899354E (pt) | Síntese de desoxibiotinil-hexametilenodiaminadota | |
GB0506164D0 (en) | Purification of salts |